EXOZ (eXoZymes Inc. Common Stock) Stock Analysis - Insider Trades
eXoZymes Inc. Common Stock (EXOZ) is a publicly traded Healthcare sector company. As of May 21, 2026, EXOZ trades at $9.40 with a market cap of $80.97M and a P/E ratio of -8.83. EXOZ moved -2.11% today. Year to date, EXOZ is -15.50%; over the trailing twelve months it is -10.22%. Its 52-week range spans $7.08 to $23.99. Rallies surfaces EXOZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading EXOZ stock inside the company?
Recent EXOZ insider activity includes Korman Tyler Paz sold 750, Korman Tyler Paz sold 750, and Heltzen Michael bought 1.04K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
EXOZ Key Metrics
Key financial metrics for EXOZ
Metric
Value
Price
$9.40
Market Cap
$80.97M
P/E Ratio
-8.83
EPS
$-1.09
Dividend Yield
0.00%
52-Week High
$23.99
52-Week Low
$7.08
Volume
0
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-9.16M
Gross Margin
0.00%
Recent EXOZ Insider Trades
Korman Tyler Paz sold 750 (~$7.89K) on Apr 9, 2026.
Korman Tyler Paz sold 750 (~$7.53K) on Apr 8, 2026.
Heltzen Michael bought 1.04K (~$10.63K) on Jul 2, 2025.
EXOZ analyst coverage data. Average price target: $0.00.
Common questions about EXOZ
Who is trading EXOZ stock inside the company?
Recent EXOZ insider activity includes Korman Tyler Paz sold 750, Korman Tyler Paz sold 750, and Heltzen Michael bought 1.04K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for EXOZ?
Yes. Rallies tracks EXOZ insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is EXOZ research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EXOZ. It does not provide personalized investment advice.